News

TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The IPO market remains frozen in 2025, keeping startups like Kin and M1 in limbo. Here’s why deals are stalled—and what that ...
H1 picked up provider data management software company Ribbon Health to broaden its reach into the health plan, provider ...
Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece ...
Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...
Artificial intelligence is being used as an "augmentation" to help humans do work, according to Ethan Wade from Brighton ...
Tempus AI Inc. (NASDAQ:TEM) announced the expansion of its GenAI clinical assistant, called Tempus One, with direct ...
Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor ...
Integration of ASCO Guidelines: Tempus One is integrating ASCO's clinical practice guidelines into the platform to equip physicians with the latest guidelines and information to guide personalized ...
Based on its analysis, Spruce Point stated that Tempus AI stock has the potential to fall about 50% to 60%. From the stock's ...
Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law ...